Cargando…
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
BACKGROUND: Major interest lies in the evaluation of immune infiltrate in bladder cancer. CD8+ cytotoxic lymphocytes are key effectors of adaptive immune response. OBJECTIVES: The aims of the study were to set up a standardized methodology for CD8+ lymphocytes estimation in NMIBC and investigate how...
Autores principales: | Masson-Lecomte, Alexandra, Maillé, Pascale, Pineda, Silvia, Soyeux, Pascale, Sagrera, Ana, Rava, Marta, de Maturana, Evangelina Lopez, Márquez, Mirari, Tardón, Adonina, Carrato, Alfredo, Kogevinas, Manolis, de la Taille, Alexandre, Hartmann, Arndt, Malats, Núria, Real, Paco, Allory, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503287/ https://www.ncbi.nlm.nih.gov/pubmed/36157135 http://dx.doi.org/10.3233/blc-180206 |
Ejemplares similares
-
Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis
por: Pineda, Silvia, et al.
Publicado: (2014) -
Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis
por: Czachorowski, Maciej J., et al.
Publicado: (2012) -
Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models
por: López de Maturana, E., et al.
Publicado: (2016) -
Application of Multi-SNP Approaches Bayesian LASSO and AUC-RF to Detect Main Effects of Inflammatory-Gene Variants Associated with Bladder Cancer Risk
por: de Maturana, Evangelina López, et al.
Publicado: (2013) -
Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer
por: Pineda, Silvia, et al.
Publicado: (2015)